Szekely, J.; Swangphon, P.; Nanakorn, N.; Chaimuti, P.; Nualnoi, T.; Wongwitwichot, P.; Somapa, N.; Somapa, D.; Pengsakul, T.
Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage. Vaccines 2023, 11, 1230.
https://doi.org/10.3390/vaccines11071230
AMA Style
Szekely J, Swangphon P, Nanakorn N, Chaimuti P, Nualnoi T, Wongwitwichot P, Somapa N, Somapa D, Pengsakul T.
Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage. Vaccines. 2023; 11(7):1230.
https://doi.org/10.3390/vaccines11071230
Chicago/Turabian Style
Szekely, Jidapa, Piyawut Swangphon, Natthaphon Nanakorn, Panuttha Chaimuti, Teerapat Nualnoi, Paweena Wongwitwichot, Namchoke Somapa, Denpong Somapa, and Theerakamol Pengsakul.
2023. "Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage" Vaccines 11, no. 7: 1230.
https://doi.org/10.3390/vaccines11071230
APA Style
Szekely, J., Swangphon, P., Nanakorn, N., Chaimuti, P., Nualnoi, T., Wongwitwichot, P., Somapa, N., Somapa, D., & Pengsakul, T.
(2023). Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage. Vaccines, 11(7), 1230.
https://doi.org/10.3390/vaccines11071230
